Education

Education

HOT NEWS

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in...

Business Wire India Efficacy and safety of afatinib plus pembrolizumab to be assessed in Phase II trial in patients with locally advanced or metastatic squamous...